Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China flag China · Delayed Price · Currency is CNY
22.66
+0.35 (1.57%)
Oct 30, 2026, 3:00 PM CST

SHA:600196 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,29713,10413,52413,69416,24110,317
Trading Asset Securities
2,4602,2542,5961,888928.534,241
Cash & Short-Term Investments
15,75715,35816,12015,58217,17014,558
Cash Growth
16.66%-4.73%3.45%-9.25%17.94%22.01%
Accounts Receivable
10,0159,9558,7658,4578,1726,474
Other Receivables
864.59712.79676.66636.27611.57875.26
Receivables
10,87910,6689,4429,0938,7837,538
Inventory
5,9986,2527,2597,5386,8825,473
Other Current Assets
1,9081,5431,6711,5802,4432,868
Total Current Assets
34,54333,82134,49133,79335,27930,437
Property, Plant & Equipment
23,87524,08423,41122,23916,02813,284
Long-Term Investments
29,70327,26925,86525,01225,54923,920
Goodwill
10,76010,81010,90510,85210,3379,400
Other Intangible Assets
14,44313,99914,46813,48212,47110,276
Long-Term Accounts Receivable
-213.33198.8383.0191.6677.4
Long-Term Deferred Tax Assets
937.34985.34757.78624.47442.57265.59
Long-Term Deferred Charges
10,0217,5936,2504,6754,0083,632
Other Long-Term Assets
2,5041,2801,1142,5122,8362,014
Total Assets
126,787120,054117,461113,470107,16493,306

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4,5785,1445,9976,1606,2845,064
Accrued Expenses
1,9205,6495,4085,4145,5774,807
Short-Term Debt
15,48915,53018,71114,72811,93210,629
Current Portion of Long-Term Debt
7,4685,6353,9834,4225,2304,986
Current Portion of Leases
-348.4340.98329.53184.41141.5
Current Income Taxes Payable
461.86253.91278.7250.63619.34474.22
Current Unearned Revenue
1,0671,3001,2321,2001,5451,154
Other Current Liabilities
4,3192,5631,5011,2531,9282,063
Total Current Liabilities
35,30336,42437,45333,75833,29829,318
Long-Term Debt
15,44711,86210,44413,50512,1009,049
Long-Term Leases
2,7783,0512,5422,050744.99648.36
Long-Term Unearned Revenue
589.861,7421,093959.18986.85751.82
Long-Term Deferred Tax Liabilities
3,2243,2603,2453,4453,3633,130
Other Long-Term Liabilities
3,3701,8742,7513,1372,5622,029
Total Liabilities
60,71358,21457,52756,85353,05544,927

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,6702,6702,6712,6722,6722,563
Additional Paid-In Capital
-16,37716,59116,85316,99214,041
Retained Earnings
33,71032,07129,54527,50126,17023,858
Treasury Stock
-775.04-607.96-234.38-41.93-53.25-
Comprehensive Income & Other
14,700-1,769-1,313-1,300-1,198-1,266
Total Common Equity
50,30548,74247,26145,68544,58239,196
Minority Interest
15,76913,09912,67310,9319,5269,184
Shareholders' Equity
66,07461,84059,93456,61654,10948,380
Total Liabilities & Equity
126,787120,054117,461113,470107,16493,306

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
41,18236,42736,02135,03530,19125,454
Net Cash (Debt)
-25,425-21,069-19,901-19,453-13,021-10,896
Net Cash Growth
------
Net Cash Per Share
-9.65-7.96-7.45-7.29-4.99-4.25
Filing Date Shares Outstanding
2,6582,6402,6572,6722,6722,563
Total Common Shares Outstanding
2,6582,6402,6582,6722,6722,563
Working Capital
-760.21-2,604-2,96234.991,9811,118
Book Value Per Share
18.9318.4717.7817.1016.6815.29
Tangible Book Value
25,10223,93321,88821,35121,77419,519
Tangible Book Value Per Share
9.449.078.237.998.157.62
Land
-1,021943.68951.74201.31203.68
Buildings
-14,06112,92711,4717,7336,605
Machinery
-16,34715,39214,02610,7009,197
Construction In Progress
-3,0553,4354,9384,8973,618